These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research. Ceccarelli SM; Chomienne O; Gubler M; Arduini A J Med Chem; 2011 May; 54(9):3109-52. PubMed ID: 21504156 [No Abstract] [Full Text] [Related]
3. Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation. Horowitz JD; Chirkov YY Circulation; 2010 Oct; 122(16):1547-9. PubMed ID: 20921436 [No Abstract] [Full Text] [Related]
4. Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X). Fragasso G; Cattaneo N; Locatelli M; Caumo A; Pagnotta P; Piatti P; Bonini P; Chierchia SL G Ital Cardiol; 1998 Jun; 28(6):623-9. PubMed ID: 9672774 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. Lim TK; Choy AJ; Khan F; Belch JJ; Struthers AD; Lang CC Cardiovasc Ther; 2009; 27(1):49-58. PubMed ID: 19207480 [TBL] [Abstract][Full Text] [Related]
8. [Metabolism and the hypertrophied heart of the elderly]. Rupp H; Rupp TP; Maisch B Dtsch Med Wochenschr; 2005 Mar; 130(12):726-30. PubMed ID: 15776359 [TBL] [Abstract][Full Text] [Related]
9. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X. Feldman R Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic strategy and prognosis in patients with syndrome X]. Takeyama Y Nihon Rinsho; 2003 May; 61 Suppl 5():951-6. PubMed ID: 12809063 [No Abstract] [Full Text] [Related]
11. Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity. Kuhajda FP; Ronnett GV Curr Opin Investig Drugs; 2007 Apr; 8(4):312-7. PubMed ID: 17458181 [TBL] [Abstract][Full Text] [Related]
12. Syndrome X and diabetes: what is the mystery? Weiswasser JM; Nylen E; Arora S; Wakefield M; Sidawy AN Semin Vasc Surg; 2002 Dec; 15(4):216-24. PubMed ID: 12478496 [TBL] [Abstract][Full Text] [Related]
13. The contribution of I1-selective agents in the management of syndrome X. de Luca N; Argengiano L; Izzo R; Guerrera L; Iovino GL; Trimarco B Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II33-5. PubMed ID: 10874855 [No Abstract] [Full Text] [Related]
14. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus. Shafrir E; Ziv E; Saha AK; Ruderman NB Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940 [TBL] [Abstract][Full Text] [Related]